- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06493006
Promoting Sustainable and Active Mobility Among Employees and Students (DiNaMo-active)
Impact of Physically Active Versus Passive Way to Work on Physical and Mental Aspects of Health in Members at Hannover Universities: an Observational Study
Study Overview
Status
Detailed Description
Active mobility, (i.e. moving around using the own physical strength) has positive sustainability effects. The physically active way to and from college is a great untapped resources for health promotion. The aim of this sub-project is to examine the way to university in order to assess its effect on individual health depending on the means of transport.
In order to determine the status quo and changes in mobility behavior the investigators will use movement trajectories using smartphone apps or inexpensive trackers in a larger cohort, as well as more specified health measures including overweight status, blood pressure, blood glucose concentration, lack of exercise, particulate matter and risk of accidents in a smaller sub-cohort.
By linking this data with the personal characteristics surveyed in other sub-projects, an evaluation of the individual health status and the expected health benefits depending on the route to work can be created. This represents the database for identifying certain groups of people or status groups who could particularly benefit from targeted promotion of an active commute.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Lower Saxony
-
Hanover, Lower Saxony, Germany, 20625
- Hannover Medical School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- living within 50km around the workplace
Exclusion Criteria:
- current participation in another interventional study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Long-term group
University members who use mainly one transport mode to get to the work place
|
|
Short-term group
University members who alternate their transport habits between physically active and passive commuting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate variability (HRV)
Time Frame: 24 hours on two separate days for the short-term subgroup, and 7 consecutive days for the long-term subgroup
|
HRV measured by a wearable activity tracker
|
24 hours on two separate days for the short-term subgroup, and 7 consecutive days for the long-term subgroup
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood glucose concentration
Time Frame: 24 hours on two separate days for the short-term subgroup
|
Intraindividual difference in blood glucose concentration between active and passive commuting as assessed with continuous blood glucose monitoring (Freestyle Libre 3)
|
24 hours on two separate days for the short-term subgroup
|
|
Work-Ability-Index
Time Frame: Once at baseline for both study subgroups
|
Interindividual difference between work ability as assessed with the Work-Ability-Index-Questionnaire. By adding up the points obtained from the questionnaire, scores can range from 7 to 49 points. The lower the score, the greater the discrepancy between the job demands placed on the respondent and their individual ability to cope with them. |
Once at baseline for both study subgroups
|
|
24 hour blood pressure
Time Frame: 24 hours on two separate days for the short-term subgroup
|
Intraindividual difference in 24 hour arterial blood pressure between active and passive commuting as assessed with 24 hour systolic and diastolic blood pressure monitoring (Boso TM-2450)
|
24 hours on two separate days for the short-term subgroup
|
|
Daily moderate to vigorous physical activity (MVPA) duration
Time Frame: 7 consecutive days for the long-term subgroup
|
Interindividual difference in MVPA as assessed with a wearable activity tracker (Garmin Smartwatch Forerunner 55)
|
7 consecutive days for the long-term subgroup
|
|
Health-related quality of life
Time Frame: Once at baseline for both study subgroups
|
Interindividual difference between health-related quality of life as assessed with the Short Form 36 questionnaire.
The possible score ranges from 0 to 100 points, with 0 points representing the greatest health impairment, while 100 points indicate no health impairment.
|
Once at baseline for both study subgroups
|
|
Particulate matter
Time Frame: 24 hours on two separate days for the short-term subgroup
|
Intraindividual difference in particulate matter concentration between active and passive commuting as assessed with a particulate matter measuring module
|
24 hours on two separate days for the short-term subgroup
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Uwe Tegtbur, Prof. Dr., Hannover Medical School, Clinic of Rehabilitation and Sports Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 01UV2301B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.